Skip to content

INPHAR

Active Public limited companyfounded 2002active for 24 yearsDorpsstraat 138, 9980 Sint-LaureinsKBO/BCE: BE 0477.970.765 subsidiary of

Lifetime

20 annual accounts with figures on one time axis, 24 filings since 2002
peak of €227,469 in 2025
€227,469▲ €231,718
lowest -€63,203 in 2012
€174,466▲ €181,313
peak of €208,296 in 2021
€86,096▼ 49.8%
€311,470 
peak of 0 FTE in 2019
-not published
Board2 names since 2022
2 directors and 1 other
Owners
100%
Documentsfilings and deeds
31-08-202631 days late
2025micro format
Gross margin from -€4,249 to €227,469Profit of €174,466, after a lossDividend €260,000Equity from €171,630 to €86,096

Key points

from the 2025 annual accounts

Equity

€86,096 ▼ 49.8%
171,6302024+174,466Profit-260,000Dividend86,0962025

INPHAR paid out €260,000 in dividends. That is 149% of the 2025 profit.

Result

€174,466 €174,466
-€6,8502024€174,0002025

Back in profit in 2025, after a loss of €6,846 in 2024.

Debts

€311,470 78% of the balance sheet
2025 accounts filed 31 days after the deadline

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 3,821 companies had the same profile as INPHAR has now. Each dot stands for 10 companies, two years later.

95.1%
were still trading
3.8%
stopped another way
1.0%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 3,821 companies, not a prediction for INPHAR. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Managing director,
Director
  • 100%equity €2.7m (2025) · annual accounts 2025 of
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0477970765
2 directors appointed, 2 resignations (managing director) and resign · (director) and (director) appointed · acts as permanent representative · Board meeting of 30-09-2022 · Gazette deed
Registered office moved within Bruges The registered office moved from Willem de Dekenstraat 3/7, 8000 Brugge to Willem de Dekenstraat 3/0301, 8000 Brugge · Board meeting of 31-08-2019 · Gazette deed
(managing director) and (director) reappointed General meeting of 27-05-2017 · Gazette deed
All 41 events

Official details

Source: KBO
Status
Active since 16-07-2002Normal situation
Activity
Retail sale of pharmaceutical productsNACE 477301 activity on the establishment unitFrom the articles, 4 activities
Establishment unit
2.114.467.0699980 Sint-Laureins, since 30-09-2002
Financial year end
31 December
Peppol
Reachable since 28-01-2026
Company details

Annual accounts 2025

≈ €560,000estimated
€397,566▲ 132%
Filing
Filed on 31-08-2026
Financials

Insights on INPHAR

INPHAR files the micro format. That format states no turnover. The gross margin rose from €21,589 in 2006 to €227,469 in 2025.

holds all the shares. In November 2022, the Official Gazette published the appointment of as managing director.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about INPHAR

What is the company number of INPHAR?
The company number of INPHAR is 0477.970.765. The VAT number is the same number with BE in front: BE 0477.970.765.
Where is INPHAR based?
The registered office is at Dorpsstraat 138, 9980 Sint-Laureins.Company details
What does INPHAR do?
According to the KBO register, the main activity of the establishment unit is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of INPHAR?
INPHAR is a public limited company (NV).
When was INPHAR founded?
INPHAR was founded on 16-07-2002.
Is INPHAR still active?
Yes, INPHAR is an active enterprise in the KBO register.
What is the turnover of INPHAR?
The turnover in financial year 2025 is about €560,000. This figure is estimated from the gross margin of €227,469 and 2,454 comparable companies of the same size. It probably lies between €370,000 and €880,000. It is a rough estimate.Financials
Is INPHAR profitable?
In financial year 2025, INPHAR made a profit of €174,466.
Where can I find the annual accounts of INPHAR?
INPHAR filed 24 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of INPHAR due?
INPHAR must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.